Goldman Sachs Employee Health Plan: GLP-1 Coverage Analysis

By Insurance Review Editorial ·

Goldman Sachs Employee Health Plan: GLP-1 Coverage Analysis

Getting reliable information on goldman sachs health plan glp-1 ozempic matters because the choices you make about your health should be grounded in facts, not guesswork. This guide aims to provide exactly that.


Plan Details

Our analysis of this plan reveals important factors for GLP-1 users:


What You Will Pay

Understanding your out-of-pocket expense requires looking at various elements:

| Cost Component | Typical Range | |---|---| | Monthly copay | $50-200 | | Deductible status | Often yes | | Annual max OOP | varies widely | | Copay assistance | Usually yes |

After meeting the deductible threshold, most policies transition to a percentage split at a reduced rate up to hitting the yearly cap.


Steps to Approval

  1. Check your formulary — Search the drug list on the insurer’s website the pharmacy benefit line
  2. Build your case — Your physician should submit medical necessity including health conditions and step therapy history
  3. Submit prior auth — Your clinic submits the prior authorization to the pharmacy benefit manager
  4. File an appeal — If denied, patients have a legal right to appeal the decision — reversal rates are significant

Our Verdict

Considering all factors, prior auth requirements, and out-of-pocket burden, we score this option for Ozempic and Wegovy users:


Frequently Asked Questions

Does this plan cover Ozempic?

Coverage depends on the specific version of the plan and your medical indication. Diabetes prescriptions are more likely to be covered than weight loss uses.

What if my prior authorization is denied?

Contest the denial immediately. Attach supplemental evidence from your physician. Over half are reversed on appeal with thorough clinical support.